| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65862-752-50 | 65862-752 | HUMAN PRESCRIPTION DRUG | Cefixime | cefixime | POWDER, FOR SUSPENSION | ORAL | 20150414 | N/A | ANDA | ANDA204835 | Aurobindo Pharma Limited | CEFIXIME | 200 mg/5mL | 50 mL in 1 BOTTLE (65862-752-50) |
| 65862-752-75 | 65862-752 | HUMAN PRESCRIPTION DRUG | Cefixime | cefixime | POWDER, FOR SUSPENSION | ORAL | 20150414 | N/A | ANDA | ANDA204835 | Aurobindo Pharma Limited | CEFIXIME | 200 mg/5mL | 75 mL in 1 BOTTLE (65862-752-75) |
| 65862-751-01 | 65862-751 | HUMAN PRESCRIPTION DRUG | Cefixime | cefixime | POWDER, FOR SUSPENSION | ORAL | 20150414 | N/A | ANDA | ANDA204835 | Aurobindo Pharma Limited | CEFIXIME | 100 mg/5mL | 100 mL in 1 BOTTLE (65862-751-01) |
| 65862-751-50 | 65862-751 | HUMAN PRESCRIPTION DRUG | Cefixime | cefixime | POWDER, FOR SUSPENSION | ORAL | 20150414 | N/A | ANDA | ANDA204835 | Aurobindo Pharma Limited | CEFIXIME | 100 mg/5mL | 50 mL in 1 BOTTLE (65862-751-50) |